Role of increased circulating and renal adrenomedullin in rats with malignant hypertension
Toshio Nishikimi(Kyoto University), Kenji Kangawa(National Cerebral and Cardiovascular Center), Fumiki Yoshihara(National Cerebral and Cardiovascular Center), Ichiro Okano, Hisayuki Matsuo(National Cerebral and Cardiovascular Center), Takeshi Horio, Noritoshi Nagaya(National Cerebral and Cardiovascular Center), Chikao Yutani(Saiseikaisenri Hospital), Hiroaki Matsuoka(Social Welfare Department), Akio Kanazawa(Juntendo University)
American Journal of Physiology-Regulatory, Integrative and Comparative Physiology
December 1, 2001
Cited by 27
Related Papers
Plasma Brain Natriuretic Peptide as a Prognostic Indicator in Patients With Primary Pulmonary Hypertension
|Circulation|2000|880
Plasma Brain Natriuretic Peptide Levels Increase in Proportion to the Extent of Right Ventricular Dysfunction in Pulmonary Hypertension
|Journal of the American College of Cardiology|1998|578
Erratum: The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2009)—Chapter 2
|Hypertension Research|2009|485
The role of natriuretic peptides in cardioprotection
|Cardiovascular Research|2005|483
Plasma levels of adrenomedullin, a newly identified hypotensive peptide, in patients with hypertension and renal failure.
|Journal of Clinical Investigation|1994|478